Proton Pump Inhibitor-Bismuth-Tetracycline-Levofloxacin Quadruple Therapy Achieves a Higher Eradication Rate than Standard Levofloxacin-Containing Triple Therapy in the Second-Line Treatment of Helicobacter Pylori Infection and a Randomized Controlled Trial

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Eradication Rate ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial

The American Journal of Gastroenterology ◽

10.1038/ajg.2017.195 ◽

2017 ◽

Vol 112 (9) ◽

pp. 1374-1381 ◽

Cited By ~ 14

Author(s):

Ping-I Hsu ◽

Feng-Woei Tsai ◽

Sung-Shuo Kao ◽

Wen-Hung Hsu ◽

Jin-Shiung Cheng ◽

...

Keyword(s):

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Triple Therapy ◽

Proton Pump ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Su1281 – Tetracycline-Levofloxacin Quadruple Therapy Achieves a Higher Eradication Rate Than Amoxicillin-Levofloxacin Quadruple Therapy in the Second-Line Treatment of Helicobacter Pylori Infection — a Randomized Controlled Trial

Gastroenterology ◽

10.1016/s0016-5085(19)38206-x ◽

2019 ◽

Vol 156 (6) ◽

pp. S-529

Author(s):

Ping-I Hsu ◽

Deng-Chyang Wu ◽

Consortium Taiwan Acid-Related Disease and Microbiota (TARD-M)

Keyword(s):

Helicobacter Pylori ◽

Eradication Rate ◽

Controlled Trial ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial

PLoS ONE ◽

10.1371/journal.pone.0183302 ◽

2017 ◽

Vol 12 (9) ◽

pp. e0183302 ◽

Cited By ~ 6

Author(s):

Daniela Munteanu ◽

Ohad Etzion ◽

Gil Ben-Yakov ◽

Daniel Halperin ◽

Leslie Eidelman ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

Second Line ◽

Efficacy And Safety ◽

Quadruple Therapy ◽

Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

Medicine ◽

10.1097/md.0000000000013245 ◽

2018 ◽

Vol 97 (46) ◽

pp. e13245 ◽

Cited By ~ 2

Author(s):

Hyun Lim ◽

Chang Seok Bang ◽

Woon Geon Shin ◽

Jae Ho Choi ◽

Jae Seung Soh ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Quadruple Therapy ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

First Line Treatment

Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial

Wiener klinische Wochenschrift ◽

10.1007/s00508-008-1122-2 ◽

2009 ◽

Vol 121 (1-2) ◽

pp. 47-52 ◽

Cited By ~ 15

Author(s):

Josip Bago ◽

Branko Pevec ◽

Monika Tomić ◽

Marinko Marušić ◽

Vinko Bakula ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

Second Line ◽

Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dks361 ◽

2012 ◽

Vol 68 (1) ◽

pp. 222-228 ◽

Cited By ~ 32

Author(s):

C.-H. Kuo ◽

P.-I. Hsu ◽

F.-C. Kuo ◽

S. S. W. Wang ◽

H.-M. Hu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

High Dose ◽

Second Line ◽

Quadruple Therapy ◽

Faculty Opinions recommendation of Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958698.793463933 ◽

2012 ◽

Author(s):

Direk Limmathurotsakul

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

High Dose ◽

Second Line ◽

Quadruple Therapy ◽

Bismuth-Based Quadruple Therapy Versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3839451 ◽

2021 ◽

Author(s):

Seung In Seo ◽

Hyun Lim ◽

Chang Seok Bang ◽

Young Joo Yang ◽

Gwang Ho Baik ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Quadruple Therapy ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

First Line Treatment

Is there randomized controlled trial evidence to determine the optimum duration of triple therapy (proton pump inhibitor and two antibiotics) for Helicobacter pylori eradication?

Cochrane Clinical Answers ◽

10.1002/cca.498 ◽

2016 ◽

Author(s):

Ulrich Ronellenfitsch

Keyword(s):

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Triple Therapy ◽

Proton Pump ◽

Controlled Trial ◽

Helicobacter Pylori Eradication ◽

Randomized Controlled ◽

Optimum Duration ◽

Trial Evidence

Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized-controlled trial

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2006.03234.x ◽

2006 ◽

Vol 25 (5) ◽

pp. 585-592 ◽

Cited By ~ 7

Author(s):

A. S. RAGHUNATH ◽

A. P. S. HUNGIN ◽

J. MASON ◽

W. JACKSON

Keyword(s):

Primary Care ◽

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Helicobacter Pylori Eradication ◽